Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
AlcoholismSubstance-Related Disorders
Interventions
DRUG

intranasal oxytocin spray

6 insufflations (24 IU of oxytocin total) given twice daily, day 1-3. 2 insufflations (8 IU of oxytocin total) as needed, max thrice daily, day 3-30 Day 30 - 12 months: No further oxytocin treatment, i.e. treatment-as-usual.

OTHER

intranasal spray without oxytocin

6 insufflations (24 IU of placebo total) given twice daily, day 1-3. 2 insufflations (8 IU of placebo total) as needed, max thrice daily, day 3-30 Day 30 - 12 months: No further oxytocin treatment, i.e. treatment-as-usual.

Trial Locations (1)

Unknown

Lade Addiction Treatment Center, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

Lade Addiction Treatment Center

UNKNOWN

lead

Norwegian University of Science and Technology

OTHER

NCT03339024 - Intranasal Oxytocin Effects in Alcohol Withdrawal and Dependence; Follow-up Study | Biotech Hunter | Biotech Hunter